Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

NCT03262116 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Devices are not available

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Humalog
DRUG: Novolog
DRUG: BC222 insulin lispro
DEVICE: Bionic Pancreas

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]